Has Scott Safir, MD received payments from drug or device companies?

Yes. Drug and device makers reported $24,926 in general payments to Scott Safir, MD across 324 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Scott Safir, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Scott Safir, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Scott Safir, MD

Vascular Surgery · Mineola, NYNPI 1720473309

Payments from drug & device makers

$24,926in general payments, 2019–2025

Across 324 payments — averaging $76.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Cagent Vascular Inc$8K
Cook Incorporated$3K
Shockwave Medical, Inc$3K
Cook Medical LLC$3K
Medtronic$2K
Boston Scientific$1K
plus $5K from 18 others

What the payments were for

Consulting fees$4,00016%
Speaking & faculty fees$3,02512%
Travel & lodging$4,70919%
Food & beverage$13,18653%
Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Cagent Vascular Inc	18	$7,890
Cook Incorporated	4	$3,016
Shockwave Medical, Inc	25	$2,833
Cook Medical LLC	120	$2,727
Medtronic	36	$2,291
Boston Scientific	35	$1,318
Silk Road Medical, Inc.	7	$803
Tactile Systems Technology Inc	22	$686
Penumbra, Inc.	8	$605
Globus Medical	6	$537
BD	3	$475
Smith+Nephew	17	$373
Endologix LLC	4	$298
Bard Peripheral Vascular, Inc.	2	$298
W. L. Gore & Associates, Inc.	3	$233
Terumo Medical Corporation	3	$216
Inari Medical, Inc.	1	$120
Lemaitre Vascular, Inc.	2	$44
Mozarc Medical US LLC	2	$40
OPKO Pharmaceuticals, LLC	2	$36
Surgical Specialties Corporation (US), Inc. (dba Corza Medical)	1	$33
Stryker	1	$28
E.r. Squibb & Sons, L.L.C.	1	$19
Cardiovascular Systems Inc.	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Serrantor$7,670
Zilver PTX$3,679
Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$2,579
ENDURANT IIS$766
ENROUTE Transcarotid Neuroprotection System$677
ENROUTE Transcarotid Stent$677
ADVANCE$434
HawkOne$422
Indigo System$368
IN.PACT Admiral$273
MARS Lateral ALIF$203
Azur CX Detachable$175
MARS Anterior Retractor$158
Lutonix Drug Coated Balloon$158
GORE VIABAHN VBX Balloon Expandable Endo$150
JETSTREAM SC$149
Rubicon 18$146
VENOUS WALLSTENT$145
Endurant$145
Alto Abdominal Stent Graft System$142

How this compares

$24,926 in reported general payments places this provider in the 75th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York →

Medicare billing

Part B allowed, 2024

$279,016

Medicare patients

424

Services billed

1,188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	18	$12,832
ClopidogrelClopidogrel Bisulfate	33	$491
Cilostazol	30	$273
Triamcinolone Acetonide	38	$187
Gabapentin	13	$38
Tramadol Hcl	13	$30
Oxycodone Hcl	12	$27

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Mineola

Alisha OropalloMineola$574K
Gary GelbfishNew York$1.9M
Sundaram RavikumarDobbs Ferry$1.8M
Antonios GasparisHuntington$1.7M
John LantisNew York$1.4M
Sonya NoorBuffalo$1.2M
Brian DerubertisNew York$1M
Thomas MaldonadoNew York$1M
James McKinseyNew York$750K
Peter FariesNew York$639K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →